Nivolumab +/- Ipilimumab in Patients With Advanced, Refractory Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Tumors (NECs)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
Combined Treatment With Nivolumab and Trabectedin in Patients With Metastatic or Inoperable Soft Tissue Sarcomas
- Status
- COMPLETED
- Phase
- PHASE2
NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity Study
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Phase II Clinical Trial of NIVO-IPI-TAXANE in Untreated Metastatic NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations
- Status
- COMPLETED
- Phase
- PHASE2
Improving the Outcome of High-risk Aggressive B-cell Lymphoma Patients With Nivolumab Maintenance Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2